Panasonic's (NASDAQOTH: PCRFY ) not the first company you may think of in the health-care field, but this Japanese electronics maker's a player in blood glucose monitors and other fields. With Panasonic's sales under fire across the board, however, this company's looking to sell off its health-care business to refocus on its core segments. Toshiba (NASDAQOTH: TOSBF ) reportedly has expressed interest in a buy, and private equity-firms are also in the hunt to get on board with Asia's health-care rise.
Buying into the Asian health-care scene isn't anything new. Stryker (NYSE: SYK ) made waves earlier this year by purchasing Chinese spine and trauma firm Trauson for $764 million, and with China's health-care industry still in a state of transition, this is a potent grow opportunity for device firms. But is Panasonic's business worth all that much to buyers? Motley Fool contributor Dan Carroll and health-care analyst Max Macaluso discuss what you need to know in the following video.
Hot Defense Companies To Own For 2016: EXCO Resources NL(XCO)
EXCO Resources, Inc., an independent oil and natural gas company, engages in the exploration, exploitation, development, and production of onshore North American oil and natural gas properties with a focus on shale resource plays. The company holds interests in various projects located in East Texas, North Louisiana, Appalachia, and the Permian Basin in west Texas. As of December 31, 2010, it had proved reserves of approximately 1.5 trillion cubic feet equivalent; and operated 7,276 wells. The company was founded in 1955 and is based in Dallas, Texas.
Advisors' Opinion:- [By Victor Selva]
This first month of the year has been successful for EXCO Resources Inc. (XCO) as three hedge fund managers have invested in it. They are: Prem Watsa (Trades, Portfolio), which added the stock at an average price of $4.88 and currently holds 17.538.912 shares, Wilbur Ross (Trades, Portfolio) also added the stock at $4.74 holding 51.107.800 shares and finally, Howard Marks (Trades, Portfolio) at an average price of $4.99 and 45.251.182 shares of the stock.
10 Best Japanese Stocks To Buy Right Now: CVR Partners LP(UAN)
CVR Partners, LP engages in the production of nitrogen fertilizers including ammonia and urea ammonium nitrate. The company was incorporated in 2007 and is based in Sugar Land, Texas. CVR Partners, LP operates as a subsidiary of CVR Energy, Inc.
Advisors' Opinion:- [By Eric Volkman]
A sizable block of units of�CVR Partners (NYSE: UAN ) is on the move. A subsidiary of the company, Coffeyville Resources, is offering 12-million common units of its parent in a secondary public offering priced at $25.15 per unit. Also, the offering's underwriters have been granted a 30-day option to buy up to an additional 1.8 million units from the seller.
- [By Robert Rapier]
Enter CVR Partners LP (NYSE: UAN), the only company in the US to produce fertilizer from petroleum coke (petcoke). Petcoke is a byproduct of petroleum refining, and prices are usually set off coal prices, since these two products compete in the same niche. Thus the same dynamics that currently threaten the distributions of Rentech Nitrogen Partners and Terra Nitrogen Company play in CVR Partners’ favor.
- [By Cameron Swinehart]
Going forward I will be looking to add investments on my watchlist and trim other positions. It will be interesting to see how an overweight commodity portfolio will perform relative to the rest of the market.
Cost Basis# SharesCurrent Price% of PortfolioCurrent ValueReturnMetal/Miners Sprott Physical Gold Trust (PHYS)$12.4985$11.043.75%$938.40-13.13%Sprott Physical Silver Trust (PSLV)$7.95125$8.744.37%$1,092.509.04%FreePort-McMoran (FCX)$31.6731$33.874.20%$1,049.976.50%Ishares MSCI Global Gold Miners ETF (RING)$13.0695$10.644.04%$1,010.80-22.74%Energy Statoil ASA(STO)$21.7940$22.683.63%$907.203.92%Vanguard Natural Resources LLC (VNR)$27.5636$27.874.01%$1,003.321.11%ConocoPhillips (COP)$63.6822.43$71.006.37%$1,592.5310.31%Agriculture CVR Partner LP (UAN)$26.3630.9$18.932.34%$584.94-39.25%Adecoagro$6.78125$7.443.72%$930.008.87%Archer-Daniels Midland (ADM)$34.8030$37.244.47%$1,117.206.55%Mixed Commodity Powershares DB Commodity Index (DBC)$26.3540$25.954.15%$1,038.00-1.54%Sprott Resource Corp$3.34400$2.714.34%$1,084.00-23.25% Total % of portfolio49.40% Cost Basis12,666.00 Current Value12,348.86 Return-2.50% Source: Investing For The Future Surge In Commodity PricesDisclosure: I am long ADM, FCX, UAN, AGRO, RING, VNR, SCPZF.PK, COP, DBC, PHYS, PSLV. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, nitrogen fertilizer producer CVR Partners (NYSE: UAN ) has earned a coveted five-star ranking.
10 Best Japanese Stocks To Buy Right Now: Vanguard FTSE All World ex US Index Fund Investor Shares (VEU)
Vanguard FTSE All-World ex-US ETF (the Fund) is an exchange-traded class of shares of Vanguard FTSE All-World ex-US Index Fund. The Fund seeks to track the performance of an index that measures the investment return of stocks of companies located in developed and emerging markets worldwide. The Fund employs a passive management or indexing investment approach designed to track the performance of the FTSE All-World ex US Index (the Index), a free-float-adjusted, market capitalization-weighted index designed to measure equity market performance of international markets.
The Index includes approximately 2,200 stocks of companies located in 47 countries, including both developed and emerging markets. The Fund typically holds 1,200 to 1,300 stocks in the Index (covering nearly 95% of the Index�� total market capitalization) and a representative sample of the remaining stocks. The Fund holds a range of securities that, in the aggregate, approximate the full Index in terms of key characteristics. These key characteristics include industry weightings and market capitalization, as well as certain financial measures, such as price/earnings ratio and dividend yield. The Fund�� investment advisor is The Vanguard Group, Inc.
Advisors' Opinion:- [By Philip Springer, President, Retirement Wealth Management, Inc.]
Our favorite is Vanguard FTSE All-World ex-US (VEU). This all-in-one ETF combines broad diversification, a high yield (4.7%) and a rock-bottom expense ratio (0.15%).
10 Best Japanese Stocks To Buy Right Now: NYSE Euronext Inc.(NYX)
NYSE Euronext, through its subsidiaries, operates securities exchanges. It operates various stock exchanges, including the New York Stock Exchange (NYSE), NYSE Arca, Inc., and NYSE Amex LLC in the United States; and five European-based exchanges that comprise Euronext N.V. ? the Paris, Amsterdam, Brussels, and Lisbon stock exchanges, as well as the NYSE Liffe derivatives markets in London, Paris, Amsterdam, Brussels, and Lisbon. The company?s Derivatives segment provides access to trade execution in derivatives products, options, and futures; offers clearing services for derivative products; and sells and distributes market data and related information. NYSE Euronext?s Cash Trading and Listings segment engages in offering access to trade execution in cash trading and settlement of transactions in European markets; obtaining new listings and servicing existing listings; selling and distributing market data and related information; and providing regulatory services. Its Info rmation Services and Technology Solutions segment operates sell side and buy side connectivity networks for its markets and for other market centers, and market participants in the United States, Europe, and Asia; provides trading and information technology software and solutions; sells and distributes market data and related information to data subscribers for proprietary data products; and offers asset management services, and consultancy services to exchanges and liquidity centers. The company is headquartered in New York, New York.
Advisors' Opinion:- [By Alex Planes]
The New York Stock Exchange -- the larger part of NYSE Euronext (NYSE: NYX ) -- moved into its present home on 18 Broad Street (on the corner of Broad and Wall Street) on April 22, 1903. It was an architectural marvel for its time, with a massive open trading floor without any supporting columns, huge windows, six miles of pneumatic tubes for routing orders, and one of the world's first air-conditioning systems. Even if you've never visited this iconic location, you're probably well-acquainted. It is one of the most famous buildings in the world:
- [By Dave Michaels]
Such systems, or SIPs, are owned by the two major exchange operators -- The Nasdaq OMX Group Inc. (NDAQ) and NYSE Euronext. (NYX)
The SEC�� rule proposal, known as Regulation SCI, would require exchanges, SIPs and clearing firms to adopt policies to prevent failures, stress test their systems to ensure trading continues through a disruption, such as a software glitch or natural disaster, and report the disruptions to the SEC. The rule also would cover exchange competitors known as alternative trading systems, including dark pools. The SEC has said 10 dark pools are large enough to be subject to the regulation, based on data from 2012.
10 Best Japanese Stocks To Buy Right Now: Rigel Pharmaceuticals Inc.(RIGL)
Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.
Advisors' Opinion:- [By Max Macaluso, Ph.D.]
Early Tuesday morning, Rigel Pharmaceuticals� (NASDAQ: RIGL ) and its now-ex-partner, AstraZeneca (NYSE: AZN ) , reported late-stage clinical trial results for the experimental rheumatoid arthritis drug Fostamatinib. In the following video, health-care analyst Max Macaluso discusses why Rigel dropped 18% after the news was released and the risks that lie ahead for Rigel Pharmaceuticals.
- [By Sean Williams]
It wasn't nearly as exciting a week for Rigel Pharmaceuticals (NASDAQ: RIGL ) , which regained full rights to rheumatoid arthritis pill Fostamatinib from AstraZeneca�on Tuesday. The pair actually reported a statistically significant ACR20 response rate at 24 weeks in two trials, but the data isn't expected to be conclusive enough to gain FDA approval. AstraZeneca, not wanting to spend any more on the program, took a $140 million charge and returned all licensing back to Rigel. With the prospect of high trial costs and a drug which did well, but perhaps not well enough to compete with competition already on the market, Rigel is now in a tough position and is worth avoiding at all costs.
10 Best Japanese Stocks To Buy Right Now: Susquehanna Bancshares Inc.(SUSQ)
Susquehanna Bancshares, Inc., through its subsidiaries, provides retail and commercial banking, and financial services in the mid-Atlantic region. Its retail banking services include checking, savings, and club accounts, as well as check cards, debit cards, money market accounts, certificates of deposit, individual retirement accounts, home equity lines of credit, residential mortgage loans, home improvement loans, automobile loans, personal loans, and Internet banking services. The company?s commercial banking services comprise business checking accounts, cash management services, money market accounts, land acquisition and development loans, commercial loans, floor plan, equipment and working capital lines of credit, small business loans, and Internet banking services. It also offers commercial, property, and casualty insurance; and risk management programs for medium and large sized companies. In addition, it provides traditional trust and custodial services, as well a s acts as an administrator, executor, guardian, and managing agent for individuals, businesses, and non-profit entities. Further, the company offers investment advisory, asset management, and brokerage services for institutional and high net worth individual clients; and provides retirement planning services. Additionally, it engages in the equity management of assets for institutions, pensions, endowments, and high net worth individuals; and provides consumer vehicle financing services. The company operates 221 branches and 26 free-standing automated teller machines. Susquehanna Bancshares, Inc. was founded in 1982 and is based in Lititz, Pennsylvania.
Advisors' Opinion:- [By Rich Duprey]
Financial services holding company�Susquehanna Bancshares (NASDAQ: SUSQ ) announced yesterday its third-quarter dividend of $0.08 per share, the same rate it paid last quarter after raising the payout 14%, from $0.07 per share.
- [By Johanna Bennett]
BB&T Corp. (BBT) agreed to buy Susquehanna Bancshares (SUSQ) for about $2.5 billion in cash and stock. Shares of BB&T fell 1.7%, while shares of Susquehanna surged 32.5% to end at $13.12.
10 Best Japanese Stocks To Buy Right Now: Insmed Inc.(INSM)
Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. The company primarily focuses on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. Its lead product candidate includes ARIKACE, an inhaled antibiotic supported by positive phase 2 results for treating serious lung infections due to susceptible bacteria. The U.S. Food and Drug Administration has cleared the company's investigational new drug application to conduct a pivotal Phase 3 clinical trial of ARIKACE in nontuberculous mycobacteria lung infections. Insmed Incorporated was founded in 1999 and is based in Monmouth Junction, New Jersey.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Monday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Nordion (NYSE: NDZ) and Insmed (NASDAQ: INSM). - [By Eric Volkman]
Insmed (NASDAQ: INSM ) will have nearly $60 million at its disposal if a new public stock offering goes as planned. The company is floating 6 million shares of its common stock in a public issue that has been priced at $10.40 per share. The gross take will be $62.4 million, which the firm said should net it around $58 million after fees and expenses.
No comments:
Post a Comment